Session Details
Date & Time
Tuesday, April 20, 2027, 1:20 PM - 2:00 PM
Name
02. The Economics of Affordable Cell and Gene Therapy
Session Type
Panel
Speakers
- Bhavesh Shah, RPh, Vice President and Chief Pharmacy Officer, Boston Medical Center
- Elisabeth King, DNP, MBA, Vice President, Operations at TGH Cancer Institute, Tampa General Hospital; Chief Operating Officer, Cancer Center of South Florida
- Justin Konkol, PharmD, MHA, DPLA, Executive Director, Froedtert ThedaCare Health
- Laila Craveiro, DNP, Executive Director, Ambulatory Oncology Services, Apheresis, and Cellular Therapy Program, Knight Cancer Institute, Oregon Health & Science University
- Nik Buescher, Vice President, Oncology, Penn Medicine Lancaster
Description
Cell and gene therapies offer genuinely transformative outcomes but carry steep price tags that strain health system budgets nationwide. Oncology finance and clinical leaders discuss reimbursement models, manufacturing costs, and value-based contracting approaches all aimed at making these breakthrough treatments more financially sustainable and accessible to the patients who need them.